Prelude Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1240 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1367 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1668 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1723 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1757 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1796 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1580 |
|
|
2021
Q2 | – | Sell |
-4,159
| Closed | -$545K | – | 1528 |
|
|
2021
Q1 | $545K | Sell |
4,159
-5,741
| -58% | -$752K | 0.01% | 560 |
|
|
2020
Q4 | $1.03M | Buy |
9,900
+8,941
| +932% | +$934K | 0.03% | 210 |
|
|
2020
Q3 | $68K | Buy |
+959
| New | +$68K | ﹤0.01% | 792 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1569 |
|
|
2020
Q1 | – | Sell |
-12,423
| Closed | -$243K | – | 1333 |
|
|
2019
Q4 | $243K | Buy |
+12,423
| New | +$243K | 0.01% | 494 |
|
|
2019
Q2 | – | Sell |
-8,541
| Closed | -$174K | – | 1543 |
|
|
2019
Q1 | $174K | Buy |
8,541
+3,397
| +66% | +$69.2K | 0.01% | 485 |
|
|
2018
Q4 | $79K | Buy |
+5,144
| New | +$79K | 0.01% | 735 |
|